Perhaps a certain cynical investor thought it unwise to drum up the pro arguments when they're looking to load up some more.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025